ArticleJournal of infection and public health2020

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach.

Purushothaman Indu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.